Your browser doesn't support javascript.
loading
Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial.
Litton, J K; Hurvitz, S A; Mina, L A; Rugo, H S; Lee, K-H; Gonçalves, A; Diab, S; Woodward, N; Goodwin, A; Yerushalmi, R; Roché, H; Im, Y-H; Eiermann, W; Quek, R G W; Usari, T; Lanzalone, S; Czibere, A; Blum, J L; Martin, M; Ettl, J.
Afiliación
  • Litton JK; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jlitton@mdanderson.org.
  • Hurvitz SA; University of California, Los Angeles/Jonsson Comprehensive Cancer Center, Los Angeles, USA.
  • Mina LA; Banner M.D. Anderson Cancer Center, Gilbert, USA.
  • Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
  • Lee KH; Seoul National University Hospital, Seoul, South Korea.
  • Gonçalves A; Institut Paoli-Calmettes, Marseille, France.
  • Diab S; Rocky Mountain Cancer Centers, Littleton, USA.
  • Woodward N; Mater Misericordiae Ltd/Mater Research Institute and the University of Queensland, Brisbane, Australia.
  • Goodwin A; Medical Oncology Department, Concord Repatriation General Hospital, Concord, Australia.
  • Yerushalmi R; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
  • Roché H; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse, Toulouse, France.
  • Im YH; Samsung Medical Center, Seoul, South Korea.
  • Eiermann W; Interdisziplinäres Onkologisches Zentrum München, Munich, Germany.
  • Quek RGW; Pfizer Inc., San Francisco, USA.
  • Usari T; Pfizer Oncology, Milan, Italy.
  • Lanzalone S; Pfizer Oncology, Milan, Italy.
  • Czibere A; Pfizer Inc., Cambridge, USA.
  • Blum JL; Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas, USA.
  • Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, Departamento de Medicina, Universidad Complutense, Madrid, Spain.
  • Ettl J; Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
Ann Oncol ; 31(11): 1526-1535, 2020 11.
Article en En | MEDLINE | ID: mdl-32828825
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article